Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Reform Bill Is Resurrected; Senate Measure Mirrors Last Year's Compromise

Executive Summary

Members of the Senate Judiciary Committee are hoping that the patent reform bill that stalled in the last Congress will finally get enough traction to pass this year.
Advertisement

Related Content

Patent Bill Drama Moves To House As Senate Hands Brand Pharma Victory
Patent Bill Drama Moves To House As Senate Hands Brand Pharma Victory
Patent Bill Clears Senate Judiciary Cmte. Unanimously, But Floor Fight Looms
House Focuses On Patent Reform, Other IP Issues With New Judiciary Subcommittee
House Focuses On Patent Reform, Other IP Issues With New Judiciary Subcommittee
House Focuses On Patent Reform, Other IP Issues With New Judiciary Subcommittee
Patent Reform Bill Is Bogged Down, Rep. Conyers Reports At Hearing
Patent Reform Bill In Senate Could Reduce "Inequitable Conduct" Litigation
Patent Reform Bill In Senate Could Reduce "Inequitable Conduct" Litigation

Topics

Advertisement
UsernamePublicRestriction

Register

PS053063

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel